Campbell Rogers is leaving his post as chief scientific officer for Johnson & Johnson’s (NYSE:JNJ) Cordis Corp. – a role created for him in July 2006 – to take the chief medical officer job at startup HeartFlow.
Personnel Moves
Cordis CSO Rogers departs for HeartFlow
Campbell Rogers is leaving his post as chief scientific officer for Johnson & Johnson’s (NYSE:JNJ) Cordis Corp. – a role created for him in July 2006 – to take the chief medical officer job at startup HeartFlow.
Report: KCI cuts 127 jobs
Kinetic Concepts Inc. (NYSE:KCI) plans to shed 127 workers with the bulk of the cuts occurring at its San Antonio, Tx. facility, according to a report in the San Antonio Express-News.
Stryker, ex- CEO MacMillan still working on exit package
Stryker Corp. (NYSE:SYK) and former CEO Stephen MacMillan are still working on the terms of a separation agreement after his abrupt resignation last week, company officials said yesterday.
In filings with the federal Securities and Exchange Commission, the company said it is "discussing the specific terms of a separation agreement with Mr. MacMillan, which will be publicly disclosed at such time as agreement is reached."
MassDevice.com +7 | The top 7 med-tech stories for the week of February 6, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
MassDevice.com +3 | The top 3 med-tech stories for February 9, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Stryker CEO: MacMillan’s abrupt resignation shocks the ortho world
Stephen MacMillan’s abrupt decision to walk away from Stryker (NYSE:SYK) for “family reasons” resonated throughout the halls of the annual confab of the orthopedic industry.
“Everyone is surprised and worried about him and his family,” Robin Young, the editor and publisher of Orthopedics This Week told MassDevice. "He’s a pretty popular guy. Even competitors liked him personally, so a lot of people are just hoping it gets resolved."
Stryker CEO Stephen MacMillan resigns for “family reasons”
Stryker Corp. (NYSE:SYK) chairman, president & CEO Stephen MacMillan walked away from one of the most successful medical device companies in the world on Wednesday, citing family reasons for an abrupt departure.
Mako Surgical names new regulatory VP | Personnel Moves
Mako Surgical (NSDQ:MAKO) tapped Lawrence Gibbons to replace its regulatory affairs vice president, James Keller, who resigned effective Feb. 3.
Gibbons, 60, was most recently with Fisher & Paykel Healthcare (NZE:FPH), where he helped establish a manufacturing facility in Mexico and set up the quality system at the company’s New Zealand headquarters.
MassDevice.com +7 | The top 7 med-tech stories for the week of January 29, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
KCI taps new CEOs, chairman | Personnel Moves
Newly privatized Kinetic Concepts Inc. is shuffling the deck, naming a new chairman, new CEOs for two of its businesses and announcing plans to spin out a third.
The wound care giant was taken private in a $6.1 billion leveraged buyout last year by Apax Partners and a pair of Canadian pension funds.